Jiangsu Hengrui Medicine Co Ltd
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and… Read more
Jiangsu Hengrui Medicine Co Ltd - Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd (600276) has an Asset Resilience Ratio of 0.16% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Jiangsu Hengrui Medicine Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Jiangsu Hengrui Medicine Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥111.45 Million | 0.16% |
| Total Liquid Assets | CN¥111.45 Million | 0.16% |
Asset Resilience Insights
- Limited Liquidity: Jiangsu Hengrui Medicine Co Ltd maintains only 0.16% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Jiangsu Hengrui Medicine Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jiangsu Hengrui Medicine Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Jiangsu Hengrui Medicine Co Ltd (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Jiangsu Hengrui Medicine Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.55% | CN¥273.34 Million | CN¥50.14 Billion | +0.32pp |
| 2023-12-31 | 0.23% | CN¥99.05 Million | CN¥43.78 Billion | -6.29pp |
| 2022-12-31 | 6.52% | CN¥2.76 Billion | CN¥42.36 Billion | -6.45pp |
| 2021-12-31 | 12.96% | CN¥5.09 Billion | CN¥39.27 Billion | -3.24pp |
| 2020-12-31 | 16.21% | CN¥5.63 Billion | CN¥34.73 Billion | -14.71pp |
| 2019-12-31 | 30.92% | CN¥8.52 Billion | CN¥27.56 Billion | -0.67pp |
| 2018-12-31 | 31.59% | CN¥7.06 Billion | CN¥22.36 Billion | +6.36pp |
| 2017-12-31 | 25.22% | CN¥4.55 Billion | CN¥18.04 Billion | +14.55pp |
| 2016-12-31 | 10.68% | CN¥1.53 Billion | CN¥14.33 Billion | +7.13pp |
| 2008-12-31 | 3.55% | CN¥80.04 Million | CN¥2.25 Billion | -9.90pp |
| 2007-12-31 | 13.45% | CN¥270.88 Million | CN¥2.01 Billion | +12.70pp |
| 2006-12-31 | 0.75% | CN¥10.97 Million | CN¥1.46 Billion | -4.25pp |
| 2003-12-31 | 5.00% | CN¥72.59 Million | CN¥1.45 Billion | -1.01pp |
| 2002-12-31 | 6.02% | CN¥72.49 Million | CN¥1.20 Billion | -4.93pp |
| 2001-12-31 | 10.95% | CN¥122.49 Million | CN¥1.12 Billion | -1.60pp |
| 2000-12-31 | 12.55% | CN¥123.75 Million | CN¥986.27 Million | -- |